Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Codeine on Pharyngeal and Esophageal Motility
NCT03784105Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Sep 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in esophageal motility disorder (EMD) comparing Codeine Sequence with Placebo Sequence (2 arms). Primary endpoints: Distal Contractile Integral at 1 week, Integrated Relaxation Pressure at 1 week and 2 more. Started Sep 2017; status: completed.
02
Drugs
codeine
03
Conditions
esophageal motility disorder (EMD)
Beyond the preview
Go deeper on NCT03784105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03784105.